Dr. Guojun Bu, associate director of the Mayo Clinic Center for Regenerative Medicine, explains how new U.S. Food and Drug Administration approval clears the way for Mayo Clinic to accelerate production of stem cells for clinical trials.
Be A Part Of Our Mission!
Join our mailing list to receive the latest news and updates from our team.
You have Successfully Subscribed!
Help Support Our Mission!
Join our team and get the latest news, events and changes in the fight for Amyloidosis!